Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
Clinical trial NCT05151848 · UNKNOWN
Trial details
- NCT number
- NCT05151848
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2026-01-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.